Review
Sep 2026
Prediabetes: Impact on cardiovascular risk and emerging therapeutic strategies.
Prediabetes is a clinically relevant cardiometabolic state and its role as an independent CV therapeutic target remains uncertain, but future trials should address phenotype-specific risk stratification and evaluate contemporary cardiometabolic therapies in appropriately powered populations.
F. Biondi, S. Ghelardoni, E. Monti et al.
· Atherosclerosis · 0 citations